MONOTILDIEM Side Effects

5255427-5 | Convulsion, Hallucination, Visual, Intentional Overdose, Renal Failure Acute, Suicide Attempt
on Feb 12, 2007 Female patient from FRANCE , 13 years of age, was treated with Monotildiem (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion, hallucination, visual, intentional overdose, renal failure acute, suicide attempt. Monotildiem dosage: 14 Tab Once Po. Patient was hospitalized.

5255261-6 | Arrhythmia, Atrial Fibrillation, Bradycardia, Hypotension
Patient was taking Monotildiem (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), atrial fibrillation (What is atrial fibrillation?), bradycardia, hypotension on Feb 12, 2007 from FRANCE Additional patient health information: Female patient , 13 years of age, . Monotildiem dosage: 14 Tab Once Po. Patient was hospitalized.

5252081-3 | Acute Respiratory Failure, Pseudomonal Sepsis
Adverse event was reported on Aug 21, 2006 by a Male patient taking Monotildiem (View Usage) (Dosage: 300 Mg Qd Po) was diagnosed with lung infection, nocardiosis and. Location: FRANCE , 81 years of age, After Monotildiem was administered, patient had the following side effects: acute respiratory failure, pseudomonal sepsis. During the same period patient was treated with KARDEGIC /00002703/ (75 Mg Qd Po) (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), NEXIUM (20 Mg Qd Po) (View Nexium Review and Nexium Label ), NITROGLYCERIN (10 Mg Q Day Td) (View Nitroglycerin Review and Nitroglycerin Label ), LASIX (1 Df Q Day Po) (View Lasix Review and Lasix Label ), BACTRIM (1 Df Q Day Po) (View Bactrim Review and Bactrim Label ), TRANXENE (View Tranxene Review and Tranxene Label ), XATRAL (View Xatral Review and Xatral Label ), PERMIXON (View Permixon Review and Permixon Label ). Patient was hospitalized.

5248596-4 | Haematotoxicity, Neutrophil Count Decreased, Platelet Count Decreased, Renal Failure Chronic
on Oct 30, 2006 Male patient from FRANCE , 73 years of age, was diagnosed with acute myocardial infarction, lung adenocarcinoma, deep vein thrombosis (What is deep vein thrombosis?) and was treated with Monotildiem (View Usage). Patient experienced the following unwanted or unexpected effects: haematotoxicity, neutrophil count decreased, platelet count decreased, renal failure chronic. Monotildiem dosage: 200 Mg Qd Po. During the same period patient was treated with CORVASAL (6 Mg Q Day Po) (View Corvasal Review and Corvasal Label ), TRIATEC (2.5 Mg Q Day Po) (View Triatec Review and Triatec Label ), VASTEN (20 Mg Qd Po) (View Vasten Review and Vasten Label ), ALIMTA (600 Mq/sqm Iv) (View Alimta Review and Alimta Label ), PREVISCAN (20 Mg Qd Po) (View Previscan Review and Previscan Label ). Patient was hospitalized.


5247657-3 | Gastrooesophageal Reflux Disease, Myocardial Infarction, Nausea
on Nov 28, 2006 Female patient from FRANCE , 79 years of age, was diagnosed with influenza immunisation, diabetes mellitus and was treated with Monotildiem (View Usage). Patient had the following side effects: gastrooesophageal reflux disease, myocardial infarction, nausea (What is nausea?). Monotildiem dosage: 300 Mg Q Day Po. During the same period patient was treated with DEPAKOTE (500 Mg Bid Po) (View Depakote Review and Depakote Label ), FLUARIX /00027001/ (1 Df Once Sc) (View Fluarix /00027001/ Review and Fluarix /00027001/ Label ), HUMALOG MIX /01293501/ (1 Df Q Day Sc) (View Humalog Mix /01293501/ Review and Humalog Mix /01293501/ Label ), TRIVASTAL (50 Mg Q Day Po) (View Trivastal Review and Trivastal Label ).